Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-05T14:53:27.949Z Has data issue: false hasContentIssue false

Transcriptome analysis during the process of in vitro differentiation of Leishmania donovani using genomic microarrays

Published online by Cambridge University Press:  07 June 2007

G. SRIVIDYA
Affiliation:
Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
R. DUNCAN
Affiliation:
Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA
P. SHARMA
Affiliation:
Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
B. V. S. RAJU
Affiliation:
Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
H. L. NAKHASI
Affiliation:
Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA
P. SALOTRA*
Affiliation:
Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
*
*Corresponding author: Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delh-110029, India. Tel: +91 11 26166124. Fax: +91 11 26166124. E-mail: salotra@vsnl.com
Rights & Permissions [Opens in a new window]

Summary

Leishmania donovani causes visceral disease (kala-azar), a major health problem throughout the tropics with 500 000 new cases every year. Leishmania differentiates from the promastigote to the amastigote form to establish infection in a mammalian host. To understand the process of differentiation, we assessed the global variation in gene expression in promastigotes, an intermediate stage of differentiation (PA24) and axenic amastigotes in culture using an L. donovani genomic microarray with 4224 clones printed in triplicate. During an intermediate stage of differentiation 24 h after shifting the promastigotes into amastigotes (PA24), there were 41 (∼1%) clones with expression ⩾2·0-fold higher than promastigotes, whereas in terminally differentiated amastigotes there were 130 (∼3%) such clones. Of particular interest were certain genes that exhibited a transient increase or decrease in expression at the PA24 stage. Kinases showed a transient increase, and surface molecules, PSA and amino acid permease, were prominent clones among those showing a brief decrease at the PA24 stage. The microarray results have been validated using Northern blots or RT-PCR. In summary, our results provide important clues about the genes involved in the differentiation process of L. donovani that may contribute to virulence.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007
Figure 0

Table 1. Clones upregulated at PA24 stage

Figure 1

Table 2. Clones down regulated at PA24 stage

Figure 2

Fig. 1. Scatter-plot comparing the log ratios against the average of the Cy3 and Cy5 intensities for each feature following LOWESS normalization using Acuity software. PA24 total RNA was used to synthesize Cy3 labelled cDNA and mixed with promastigote cDNA labelled with Cy5. The average intensity (A) of each spot is plotted along the x-axis against the LOWESS normalized log ratio (M) along the y-axis. The vertical line defines the cut off used and only spots to the right of this line were considered for analysis.

Figure 3

Fig. 2. Graphs showing various patterns of gene expression observed among clones upregulated at the PA24 stage. The log2 expression ratio in PA24/Am vs Pro is plotted at each time-point. (A) Expression pattern of clones showing transient higher expression at PA24 stage. (B) Expression pattern of clones showing uniform expression at PA24 and amastigotes compared to promastigotes. (C) Expression patterns of clones showing continuous increase in their expression during differentiation of promastigotes into amastigotes. (D) Expression pattern of clones showing transient down regulation at PA24 stage. (E) Expression patterns of clones showing down regulation at both PA24 and Am stages.

Figure 4

Fig. 3. Validation of microarray results by RT-PCR and Northern blots. Expression pattern was verified in 3 different field isolates of Leishmania donovani and representative picture with the RNA of the parasite used in the microarray is shown. The RNAs from the 3 stages were reverse transcribed and amplified by gene-specific primers using α-tubulin for normalization (A). Ethidium bromide-stained rRNA bands were used as loading controls in Northern blots (B). Fold changes at the 3 stages are indicated.